We are live on ! Find out more
PCA

Pallas Capital Advisors Portfolio holdings

AUM $3.25B
1-Year Est. Return 40.07%
This Fund
S&P 500
This Quarter Est. Return
+4.77%
1 Year Est. Return
+40.07%
3 Year Est. Return
+71.82%
5 Year Est. Return
+73.39%
10 Year Est. Return
AUM
$2.72B
AUM Growth
+$93.4M
Cap. Flow
+$34.9M
Cap. Flow %
1.29%
Top 10 Hldgs %
30.11%
Holding
964
New
105
Increased
399
Reduced
316
Closed
93

Top Sells

Rank Stock Value
1
ADBE icon
Adobe
ADBE
+$3.95M
2
ACN icon
Accenture
ACN
+$3.19M
3
PJAN icon
Innovator US Equity Power Buffer ETF January
PJAN
+$2.81M
4
FTNT icon
Fortinet
FTNT
+$2.08M
5
KMX icon
CarMax
KMX
+$1.96M

Sector Composition

Rank Sector Weight
1 Healthcare 16.95%
2 Technology 14.96%
3 Financials 7.37%
4 Industrials 6.22%
5 Consumer Discretionary 5.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KRNY icon
826
Kearny Financial
KRNY
$599M
$109K ﹤0.01%
16,633
+4,725
+40% +$30.3K
TLRY icon
827
Tilray
TLRY
$622M
$103K ﹤0.01%
5,966
+894
+18% +$8.55K
ACCO icon
828
Acco Brands
ACCO
$407M
$96.1K ﹤0.01%
+24,073
New +$93.8K
ALDX icon
829
Aldeyra Therapeutics
ALDX
$93.5M
$90.5K ﹤0.01%
17,345
-417
-2% -$2.17K
EVGO icon
830
EVgo
EVGO
$229M
$89.9K ﹤0.01%
19,000
+25
+0.1% +$97
APPS icon
831
Digital Turbine
APPS
$1.74B
$89.8K ﹤0.01%
14,034
+3
+0% +$15
XERS icon
832
Xeris Biopharma Holdings
XERS
$1.45B
$89.8K ﹤0.01%
11,027
+22
+0.2% +$146
GTN icon
833
Gray Television
GTN
$552M
$86.1K ﹤0.01%
14,895
+2,712
+22% +$14.7K
ORGO icon
834
Organogenesis Holdings
ORGO
$239M
$83.2K ﹤0.01%
19,707
+6
+0% +$28
GLUE icon
835
Monte Rosa Therapeutics
GLUE
$1.35B
$82.9K ﹤0.01%
11,194
-1,988
-15% -$10.5K
UDMY
836
DELISTED
Udemy
UDMY
$80.4K ﹤0.01%
+11,468
New +$80.4K
CRML icon
837
Critical Metals Corp
CRML
$1.06B
$79.5K ﹤0.01%
12,788
+307
+2% +$1.57K
BGS icon
838
B&G Foods
BGS
$286M
$78.4K ﹤0.01%
+17,696
New +$77.3K
RIG icon
839
Transocean
RIG
$5.82B
$75.7K ﹤0.01%
24,269
+6,669
+38% +$20.1K
BLND icon
840
Blend Labs
BLND
$386M
$70.3K ﹤0.01%
19,274
-3,054
-14% -$11K
SLDB icon
841
Solid Biosciences
SLDB
$900M
$68.8K ﹤0.01%
11,145
+103
+0.9% +$602
CMRC
842
Commerce.com Inc Series 1
CMRC
$184M
$63K ﹤0.01%
+12,627
New +$60.7K
BRY
843
DELISTED
Berry Corp
BRY
$62.9K ﹤0.01%
+16,638
New +$53.9K
OIS icon
844
Oil States International
OIS
$491M
$62.7K ﹤0.01%
10,353
-142
-1% -$779
PLTK icon
845
Playtika
PLTK
$1.12B
$60.9K ﹤0.01%
15,658
-10,807
-41% -$44.1K
GRNT icon
846
Granite Ridge Resources
GRNT
$644M
$58.7K ﹤0.01%
+10,856
New +$59.2K
JELD icon
847
JELD-WEN Holding
JELD
$164M
$55.7K ﹤0.01%
+11,335
New +$60.6K
CTKB icon
848
Cytek Biosciences
CTKB
$546M
$50K ﹤0.01%
14,405
+336
+2% +$1.26K
FF icon
849
Future Fuel
FF
$223M
$48.9K ﹤0.01%
12,607
-1,083
-8% -$4.27K
NAT icon
850
Nordic American Tanker
NAT
$1.37B
$48K ﹤0.01%
+15,276
New +$45.1K

Similar funds

Pallas Capital Advisors's Q3 2025 Portfolio in Review

As of Q3 2025, Pallas Capital Advisors held 964 positions worth $2.72B, up 3.6% from $2.63B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Pallas Capital Advisors's Q3 2025 filing shows 105 new, 399 increased, 316 reduced and 93 closed positions. Its largest new stake was JPMorgan International Value ETF: 129,744 shares worth $9.78M. The largest sale was Adobe, an estimated $3.95M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 20% a quarter earlier, followed by Technology and Financials.

  • Pallas Capital Advisors's largest Q3 2025 buy was JPMorgan International Value ETF: 129,744 shares worth $9.78M.
  • Pallas Capital Advisors added most to FT Vest Fund of Buffer ETFs in Q3 2025, an estimated $4.69M increase.
  • Pallas Capital Advisors's biggest Q3 2025 reduction was Adobe, cutting an estimated $3.95M.
  • Pallas Capital Advisors fully exited Skechers in Q3 2025, selling an estimated $1.37M.
  • Pallas Capital Advisors's ten largest holdings make up 30% of its $2.72B portfolio in Q3 2025.
  • Pallas Capital Advisors opened 105 new positions and closed 93 in Q3 2025.
  • Pallas Capital Advisors's portfolio value rose 3.6% quarter-over-quarter to $2.72B.

Based on Pallas Capital Advisors's 13F filing for Q3 2025, filed 7 Nov 2025.